Biblio Discovery — Demo Discovery Service

10 hasil untuk "Pascal Demoly, MD, PhD"

Menampilkan 1–10 · 0,19 detik · RSS

  1. Artikel Jurnal

    Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic

    Philippe Devillier, MD, PhD; Sarah Saf, MD; Christine Rolland, BA dkk.

    World Allergy Organization Journal, Vol. 17 No. 4 · 2024 · Inggris · DOAJ Scopus

    Background: The COVID-19 pandemic brought unprecedented global disruption to both healthcare providers and patients with respiratory allergies. There are limited real-life data on the impact of the COVID-19 pandemic on the risk perception of patients with allergy treated with allergen immunotherapy…

  2. Artikel Jurnal

    Hypersensitivity reactions to iodinated radiocontrast media: Cluster analysis reveals distinct clinical phenotypes

    Witchaya Srisuwatchari, MD; Tram Vo, MD; Amélie Gauthier, MD dkk.

    World Allergy Organization Journal, Vol. 15 No. 9 · 2022 · Inggris · DOAJ Scopus

    Background: Drug hypersensitivity reaction (DHR) to iodinated radiocontrast media (iRCM) is reported in 1%–3% of injections. Risk assessment of patients with suspicion of DHR to iRCM relies solely on clinical phenotyping and drug allergy workup. Using a novel unsupervised TwoStep cluster analysis…

  3. Artikel Jurnal

    Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data

    Margitta Worm, MD; Pascal Demoly, MD, PhD; Yoshitaka Okamoto, MD, PhD dkk.

    World Allergy Organization Journal, Vol. 17 No. 7 · 2024 · Inggris · DOAJ Scopus

    Background: The 300IR house dust mite (HDM) sublingual immunotherapy (SLIT) tablet is approved for treatment of HDM-induced allergic rhinitis (AR). To provide a comprehensive review of the 300IR HDM-SLIT tablet safety profile based on randomized controlled trial (RCT) pooled data and post-marketing…

  4. Artikel Jurnal

    Who is at-risk for severe anaphylaxis in France?

    Luciana Kase Tanno, MD, PhD; Pham Thao Van Luong, MD, MSc; Megane Dieval, MSc dkk.

    World Allergy Organization Journal, Vol. 17 No. 9 · 2024 · Inggris · DOAJ Scopus

    Background: The understanding of risk factors related to severe anaphylaxis is key to implementing prevention strategies. We present the first French population-based nine-year anaphylaxis hospitalization study evaluating specific trends and factors related to severe anaphylaxis (SA), to support…

  5. Artikel Jurnal

    Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology

    Davide Caimmi, MD, PhD; Pablo Rodríguez del Río, MD, PhD; Pilar Rico, MD, PhD dkk.

    World Allergy Organization Journal, Vol. 16 No. 2 · 2023 · Inggris · DOAJ Scopus

    Background: Allergen immunotherapy (AIT) is today the only etiological therapy for respiratory allergic diseases, including allergic rhinitis, allergic conjunctivitis, and allergic asthma. Even though interest in real-world data has recently increased, publications mainly focus on short-term and…

  6. Artikel Jurnal

    Anaphylaxis and pregnancy: Epidemiology, elicitors, and recurrences

    Luciana Kase Tanno, MD, PhD; Pham Thao Van Luong, MD, MSc; Megane Dieval, MSc dkk.

    World Allergy Organization Journal, Vol. 18 No. 12 · 2025 · Inggris · DOAJ Scopus

    Background: Anaphylaxis during pregnancy implies a risk to both mothers and newborns. However, limited data are available. Therefore, our aim is to explore patterns of hospital admissions diagnosed with anaphylaxis in pregnant women in France from 2012 to 2021, using a national hospital billing…

  7. Artikel Jurnal

    Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial

    Oliver Pfaar, MD, PhD; Frédéric De BLAY, MD; Giorgio Walter Canonica, MD dkk.

    World Allergy Organization Journal, Vol. 17 No. 1 · 2024 · Inggris · DOAJ Scopus

    Background: House dust mite (HDM)-induced allergic rhinitis (AR) is a major cause of allergic respiratory disease. The efficacy and safety of the 300 IR HDM sublingual immunotherapy (SLIT) tablet in patients with moderate-to-severe HDM-AR was confirmed in a large, international, phase 3 randomized…

  8. Artikel Jurnal

    CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts

    Pablo Rodriguez del Rio, MD, PhD; Davide Caimmi, MD, PhD; Pilar Rico Nieto, MD, PhD dkk.

    World Allergy Organization Journal, Vol. 16 No. 6 · 2023 · Inggris · DOAJ Scopus

    Background: There is no description of the drivers of prescription for allergen immunotherapy (AIT) for respiratory allergic diseases. Methods: A prospective, multicentre, observational, non-interventional real-life study was performed in France and Spain for 20 months. Data were gathered using 2…

  9. Artikel Jurnal

    Allergic and hypersensitivity condition in the International Patients’ Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11

    Luciana Kase Tanno, MD, PhD; Alain Perie, PhD; Jonathan A. Bernstein, MD dkk.

    World Allergy Organization Journal, Vol. 17 No. 8 · 2024 · Inggris · DOAJ Scopus

    In 2010, the United States Human and Health Services (US HHS) and the European Union's (EU) Directorate General for Communications Networks, Content and Technology signed a memorandum of understanding to stimulate cooperation surrounding health-related information communications technology. The key…